* IMS 2010

Legal terms of use

The navigation of this site is subject to the hereby legal terms of use. By accessing the information made available by United Pharmaceuticals, you are agreeing to have read and comply with the legal terms of use.

United Pharmaceuticals and all the companies that contributed to the creation and setup of this site cannot be held responsible for possible damages, direct or indirect, which may result from the use of the site. Thus, United Pharmaceuticals cannot be held responsible for a damage or virus that could infect your computer or any other type of hardware, following the use or access to the site www.novalac.com or to a download from this site.


The www.novalac.com site you are currently visiting is the property of:

United Pharmaceuticals SAS
55, Avenue Hoche
75008 Paris
+33 (0)1.55.37.22.22
RCS Paris B n° 383.184.728
Au capital de 300 000€
www.unitedpharmaceuticals.fr


Publishing Director :

Mr Jonathan MARGOSSIAN


This site has been designed by :

Eurelis
14, rue du sergent Bobillot
92400 Courbevoie – La Défense
www.eurelis.com


This site is hosted by :

OVH  SAS
2 rue Kellermann
59100 Roubaix - France.
 www.ovh.com

Intellectual Property:

Access to www.novalac.com bestows the right to private and non-exclusive use of the site. The whole of the elements edited on this site, including texts, pictures, computer graphics, logos, brands etc form a work in the sense of the term used by the Intellectual Property code. Consequently, any representation or reproduction, complete or partial, that could take place without the consent of the authors or assignees, is illegal.


www.novalac.com site unavailability:

United Pharmaceuticals is committed to making utmost efforts to ensure users have accessibility at all times. United Pharmaceuticals cannot, in any case, be held responsible for site unavailability. United Pharmaceuticals reserves the right to modify the site content at any time, in its sole discretion, and without notice.

The information contained on the site www.novalac.com cannot, in any case, substitute a medical consultation. United Pharmaceuticals provides this information purely for informative reasons.

United Pharmaceuticals tries to control the veracity of the information and to update it. Nonetheless, United Pharmaceuticals does not guarantee the accuracy, the precision, neither the updates nor the exhaustiveness of the information made available. Consequently and with the exception of a gross or intentional negligence, United Pharmaceuticals is not responsible for any damage resulting from a particular inaccuracy or misinterpretation of the information made available on this site.

Links to other sites :

United Pharmaceuticals links with third party sites at www.novalac.com. These links were established in cooperation with the sites concerned at a time when United Pharmaceuticals found it fitting, considering the content and services they provided.
United Pharmaceuticals will not be held responsible for the content of these sites nor for the manner in which other users may make use of such.

Copyright :

All texts, pictures, computer graphics, logos and brands remain the property of United Pharmaceuticals where their use is part of an agreement with their owner. They are all subject to the copyright. The partial (or complete) reproduction of this site for a strict personal use is accepted. The partial (or complete) reproduction of this site for a commercial use, as well as modifications or diffusion of elements of this site in any form is illegal.


Privacy notice :

In accordance with the recommendation 2005-284 from the CNIL (Commission Nationale de l'Informatique et des Libertés), the hereby site has not been declared as such. However, all present or future data processing on this site has been declared to the CNIL.

United Pharmaceuticals is committed to respecting the confidentiality of the personal information provided by the visitors of our site www.novalac.com.

You will find hereafter the type of information that United Pharmaceuticals can request when you visit its website, and the way in which it will be used later on.

1. Personal data collection
Some personal data is registered on our servers when you fill in online forms or when you subscribe to our newsletter. United Pharmaceuticals uses the requested personal information solely for the purposes stated on the form.

United Pharmaceuticals recommends that users do not disclose information related to their's, or their children’s health status via the site www.novalac.com .

During your visit, some data is automatically collected:
- your IP address : an IP address is given to your computer by your internet access provider in order to give you access to the Internet. This address is generally considered as identifiable impersonal information as it changes any time you get connected.
- Your login while navigating through the limited access areas.
- The website address from which you have been directly connected to www.novalac.com .
- The date and time of your visit on the site, and the pages which you consulted.
- The operating system of your computer and the web browser.

2. Use of the collected data
United Pharmaceuticals will only use the collected data to respond to the website visitors’ inquiries and to communicate new products or new services of the website, in the event that visitors specifically ask for it. United Pharmaceuticals will use the personal data solely for the purposes stated on the request form.

3. Confidentiality
United Pharmaceuticals has taken all necessary precautions to preserve the security of the data, and especially to make sure it is not modified, damaged, or that none-authorized tiers get access to it. The data is only accessible solely by a limited number of authorized persons.

The collected data can be communicated to our UP International filial. This filial is located in Switzerland, which according to the CNIL, has an adequate level of data protection.

4. Access to personal data
In accordance with the articles 38 & 40 of the 2004-801 law from 26/08/2004, you have access, modification, rectification and deletion rights over your personal data. These rights can be asked either by electronic mail sent to us or by postal mail sent to:
United Pharmaceuticals
- Service consommateurs-
55 Avenue Hoche
75008 Paris – France

Procedures to exercise the access right:

Prior to addressing the personal data to you, we will ask you to provide us with proof of identity. If you are not able to prove us your identity, we reserve the right to refuse your request and your personal data will not be sent. We are committed to answering these requests in a reasonable timeframe. In regards to the rectification, modification and deletion rights, the conditions are in accordance to those of the access rights.
 

Important notice :

Breast milk is the best food for infants. Good maternal nutrition is essential to prepare and maintain breastfeeding. If breastfeeding is not applied, an infant formula may be used according to health professionals' advice. Preparation and storage of any infant formula should be performed as directed on the tin in order not to pose any health hazards.